Literature DB >> 24904555

Unexplored hypersaline habitats are sources of novel actinomycetes.

Polpass Arul Jose1, Solomon Robinson David Jebakumar1.   

Abstract

Entities:  

Keywords:  Streptomyces; actinomycetes; antibiotic; drug discovery; hypersaline environments

Year:  2014        PMID: 24904555      PMCID: PMC4034035          DOI: 10.3389/fmicb.2014.00242

Source DB:  PubMed          Journal:  Front Microbiol        ISSN: 1664-302X            Impact factor:   5.640


× No keyword cloud information.
Pathogenic microorganisms have evolved sophisticated mechanisms to inactivate antibiotics and rendered an urgent need for new antibiotics that would target the emerging multidrug-resistance (Butler et al., 2013). Consequently, search for novel sources of potent antibiotics is desperately needed to develop potent drugs. Microbial resources have made an incredible contribution to the antibiotic drug discovery and development process over the last seven decades (Demain and Sanchez, 2009). In particular, actinomycetes are the most important source of bioactive natural compounds with a long track record of producing novel molecules, including several commercially important drugs like Streptomycin, Gentamicin, Vancomycin, Clindamycin, Erythromycin, Amphotericin, Rifampicin, and Tetracycline. More novel molecules with potential therapeutic applications are still on the row to be discovered from these actinomycetes (Baltz, 2007). Microbial assemblages and their species distributions in specific environments are mostly determined by their specific environmental conditions, which may translate into novel chemistry (Genilloud et al., 2011). The actinomycetes that produce antibiotics are abundant in soil. In recent decades, isolation and exploitation of actinomycetes for novel compounds from conventional environments have led to rediscovery of known compounds (Walsh, 2003; Tulp and Bohlin, 2005). However, diverse actinomycetes from poorly studied unusual environments promises a raise in the prospect of discovering novel compounds with potential activities that can be developed as a resource for drug discovery (Peraud et al., 2009; Jose et al., 2011; Poulsen et al., 2011; Carr et al., 2012; Subramani and Aalbersberg, 2012; Hamedi et al., 2013; Jose et al., 2013; Yuan et al., 2014). In this respect, current actinomycetes isolation programs are reoriented toward largely unexplored, unusual and extreme environments like hypersaline marine environments, extreme inland saline zones, volcanic zones, hyperarids and glaciers (Hamedi et al., 2013; Jose and Jebakumar, 2013b). The extreme habitats are characterized by chemical or physical conditions that differ significantly from those found in environments that support more abundant and varied life forms (Zhao et al., 2011). Hypersaline environments are typical extreme habitats, in which the high salt concentration, alkalinity, and low oxygen concentrations are environmental factors that may limit their biodiversity (Ventosa, 2006). There are several reports on inhabitance of microorganisms including actinomycetes in diverse hypersaline environments such as salt lakes (Swan et al., 2010; Guan et al., 2011; Phillips et al., 2012), solar salterns (Baati et al., 2008; Sabet et al., 2009), salt mines (Chen et al., 2007) and brine wells (Xiang et al., 2008). However, these hypersaline environments remain largely unexplored as a source of novel actinomycetes in many tropical and subtropical regions throughout the world. In a recent review, Hamedi et al. (2013) described that actinomycetes form a stable, metabolically active and persistent population in various marine hypersaline ecosystem and it is accepted that halophilic actinomycetes will provide a valuable resource for novel products of industrial interest, including antimicrobial, cytotoxic, neurotoxic, antimitotic, antiviral and antineoplastic activities. Series of bioactive metabolites like Pyrostatins, Salinosporamides, Abyssomicins, Trioxacarcin A, Gutingi- mycin, Sporolides, Marinomycins, Himal- omycins, Diazepinomicin, Helquinoline, Lajollamycin, Tetrodotoxin, Mecherchar- mycins, Cyanosporasides, Erythronolides, and Ammosamide D have been reported from this physiological group of actinomycetes (Hamedi et al., 2013). In continued efforts to discover novel natural products from new extremophilic actinomycetes, Zhao et al. (2011) discovered new linear polyketides, actinopolysporins A, B, and C, as well as the known antitneoplastic antibiotic tubercidin from the halophilic actinomycete Actinopolyspora erythraea YIM 90600. Tian et al. (2013) reported the isolation and characterization of p-Terphenyls with antifungal, antibacterial, and antioxidant activities from halophilic actinomycete Nocardiopsis gilva YIM 90087. Jang et al. (2013) declared a significant discovery of new antibiotic, anthracimycin, which is produced by a marine-derived actinomycete in saline culture. More recently, an antimicrobial quinoline alkaloid has been isolated from a novel halophilic actinomycete, Nocardiopsis terrae YIM 90022 (Tian et al., 2014). In accordance with the above reports, we initiated a research program which was designed to discover new natural products from novel actinomycetes originating from previously unexplored hypersaline environments. Saltpan soil samples were collected aseptically from saltpans of coastal solar saltern ponds at Arumuganeri, Tuticorin (about Latitude 8.43 N and Longitude 78.60 E) and inland solar salterns at Sambhar Lake, Jaipur (about Latitude 26.94561 N and Longitude 75.20968 E) in India. Physicochemical characteristics from this study confirmed that this environment is a hypersaline zone. In the course of our program, diverse actinomycetes were isolated by using selective isolation methods which employed stamping, heat and dilution, and succeeded with isolation of both Streptomyces (common actinomycete) and non-Streptomyces including rare actinomycetes Nonomuraea, Actinoalloteichus and Pseudonocardia (Jose and Jebakumar, 2012, 2013a). A total of 83 actinomycetes were isolated and assigned to eight genera (Streptomyces, Micromonospora, Nocardia, Nocardiopsis, Nonomuraea, Saccharopolyspora, Pseudonocardia and Actinoalloteichus) on the basis of their 16S rDNA sequences and it was the first step toward better understanding of actinomycete community from solar saltern ponds in India. Our preliminary biological activity screening and subsequent structural characterisation experiments suggested the occurrence of antimicrobial compounds producing Streptomyces and rare actinomycetes and confirmed that hypersaline solar salterns are reservoirs of antibiotic producing actinomycetes (Jose and Jebakumar, 2013a, b). The range of antimicrobial activities exerted by different actinomycete isolates were summarized in Table 1. In concise, our continuing study contributes in acquaintance of solar saltern associated actinobacteria and further augments the array of actinomycetes available for antibiotic discovery programs.
Table 1

Range of antimicrobial activities of the actinomycete isolates obtained from Indian inland (Jose and Jebakumar, .

IsolatesAntimicrobial activities
Antibacterial activityAntifungal activity
Gram—positiveGram—negativeAspergillus nigerFusarium oxysporumAlternaria alternata
Staphylococcus aureusBacillus subtilisKlebsiella pneumoniaeProteus vulgarisSalmonella typhi
Streptomyces sp. JAJ06+++++
Streptomyces sp. JAJ07+++++
Streptomyces sp. JAJ13+++++
Nonomuraea sp. JAJ18+++++
Streptomyces sp. JAJ19+++++
Micromonospora sp. JAJ20++++++++
Streptomyces sp. JAJ28+++
Streptomyces sp. JAJ41++
Streptomyces sp. JAJ59+++++
Actinoalloteichus sp. JAJ70++++++++
Streptomyces sp. JAJ73+++
Pseudonocardia sp. JAJ77+++++
Pseudonocardia sp. JAJ82+++

+, positive for antimicrobial activity; −, negative for antimicrobial activity.

Range of antimicrobial activities of the actinomycete isolates obtained from Indian inland (Jose and Jebakumar, . +, positive for antimicrobial activity; −, negative for antimicrobial activity. -In conclusion, escalating reports on discovery of diverse natural compounds from halophilic and halotolerant actinomycetes which inhabit in hypersaline environments suggested that this physiological group has enormous capacity to produce array of secondary metabolites with disparate activities. Indeed, hypersaline environments warrant significant attention as habitats of novel actinomycetes and unlock new avenues for natural products discovery.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  25 in total

Review 1.  Where will new antibiotics come from?

Authors:  Christopher Walsh
Journal:  Nat Rev Microbiol       Date:  2003-10       Impact factor: 60.633

2.  Rediscovery of known natural compounds: nuisance or goldmine?

Authors:  Martin Tulp; Lars Bohlin
Journal:  Bioorg Med Chem       Date:  2005-09-01       Impact factor: 3.641

Review 3.  Antibiotics in the clinical pipeline in 2013.

Authors:  Mark S Butler; Mark A Blaskovich; Matthew A Cooper
Journal:  J Antibiot (Tokyo)       Date:  2013-09-04       Impact factor: 2.649

4.  Antimicrobial metabolites from a novel halophilic actinomycete Nocardiopsis terrae YIM 90022.

Authors:  Shouzheng Tian; Yabin Yang; Kai Liu; Zijun Xiong; Lihua Xu; Lixing Zhao
Journal:  Nat Prod Res       Date:  2013-11-18       Impact factor: 2.861

5.  Actinopolysporins A-C and tubercidin as a Pdcd4 stabilizer from the halophilic actinomycete Actinopolyspora erythraea YIM 90600.

Authors:  Li-Xing Zhao; Sheng-Xiong Huang; Shu-Kun Tang; Cheng-Lin Jiang; Yanwen Duan; John A Beutler; Curtis J Henrich; James B McMahon; Tobias Schmid; Johanna S Blees; Nancy H Colburn; Scott R Rajski; Ben Shen
Journal:  J Nat Prod       Date:  2011-08-26       Impact factor: 4.050

6.  Phylogenetic-affiliation, antimicrobial potential and PKS gene sequence analysis of moderately halophilic Streptomyces sp. inhabiting an Indian saltpan.

Authors:  P Arul Jose; V Satheeja Santhi; Solomon R D Jebakumar
Journal:  J Basic Microbiol       Date:  2011-03-24       Impact factor: 2.281

7.  Saccharopolyspora lacisalsi sp. nov., a novel halophilic actinomycete isolated from a salt lake in Xinjiang, China.

Authors:  Tong-Wei Guan; Nan Wu; Zhan-Feng Xia; Ji-Sheng Ruan; Xiao-Ping Zhang; Ying Huang; Li-Li Zhang
Journal:  Extremophiles       Date:  2011-04-05       Impact factor: 2.395

8.  Systematic and biotechnological aspects of halophilic and halotolerant actinomycetes.

Authors:  Javad Hamedi; Fatemeh Mohammadipanah; Antonio Ventosa
Journal:  Extremophiles       Date:  2012-11-06       Impact factor: 2.395

9.  Phylogenetic appraisal of antagonistic, slow growing actinomycetes isolated from hypersaline inland solar salterns at Sambhar salt Lake, India.

Authors:  Polpass Arul Jose; Solomon Robinson David Jebakumar
Journal:  Front Microbiol       Date:  2013-07-10       Impact factor: 5.640

10.  Phylogenetic diversity and biological activity of actinobacteria isolated from the Chukchi Shelf marine sediments in the Arctic Ocean.

Authors:  Meng Yuan; Yong Yu; Hui-Rong Li; Ning Dong; Xiao-Hua Zhang
Journal:  Mar Drugs       Date:  2014-03-06       Impact factor: 5.118

View more
  11 in total

1.  Astrobiology as a framework for investigating antibiotic susceptibility: a study of Halomonas hydrothermalis.

Authors:  Jesse P Harrison; Roey Angel; Charles S Cockell
Journal:  J R Soc Interface       Date:  2017-01       Impact factor: 4.118

2.  Diversity of actinobacteria in sediments of Qaidam Lake and Qinghai Lake, China.

Authors:  Jiang Wu; Zhong Peng; Tong-Wei Guan; Han Yang; Xiaqiong Tian
Journal:  Arch Microbiol       Date:  2021-03-22       Impact factor: 2.552

3.  Bioactive Potential of Actinomycetes from Less Explored Ecosystems against Mycobacterium tuberculosis and Other Nonmycobacterial Pathogens.

Authors:  Radhakrishnan Manikkam; Gopikrishnan Venugopal; Balaji Subramaniam; Balagurunathan Ramasamy; Vanaja Kumar
Journal:  Int Sch Res Notices       Date:  2014-11-09

4.  Bioactive metabolites produced by Streptomyces Cheonanensis VUK-A from Coringa mangrove sediments: isolation, structure elucidation and bioactivity.

Authors:  Ushakiranmayi Mangamuri; Vijayalakshmi Muvva; Sudhakar Poda; Krishna Naragani; Rajesh Kumar Munaganti; Bhujangarao Chitturi; Venkateswarlu Yenamandra
Journal:  3 Biotech       Date:  2016-02-13       Impact factor: 2.406

5.  In vitro biocontrol activity of halotolerant Streptomyces aureofaciens K20: A potent antagonist against Macrophomina phaseolina (Tassi) Goid.

Authors:  P Shrivastava; R Kumar; M S Yandigeri
Journal:  Saudi J Biol Sci       Date:  2015-12-25       Impact factor: 4.219

6.  Antagonistic Properties of Some Halophilic Thermoactinomycetes Isolated from Superficial Sediment of a Solar Saltern and Production of Cyclic Antimicrobial Peptides by the Novel Isolate Paludifilum halophilum.

Authors:  Donyez Frikha Dammak; Ziad Zarai; Soumaya Najah; Rayed Abdennabi; Lassaad Belbahri; Mostafa E Rateb; Hafedh Mejdoub; Sami Maalej
Journal:  Biomed Res Int       Date:  2017-07-27       Impact factor: 3.411

Review 7.  Sampling Terrestrial Environments for Bacterial Polyketides.

Authors:  Patrick Hill; Graham W Heberlig; Christopher N Boddy
Journal:  Molecules       Date:  2017-04-29       Impact factor: 4.411

Review 8.  Antibiotic discovery: combatting bacterial resistance in cells and in biofilm communities.

Authors:  Anahit Penesyan; Michael Gillings; Ian T Paulsen
Journal:  Molecules       Date:  2015-03-24       Impact factor: 4.411

9.  New Cyclic Lipopeptides of the Iturin Class Produced by Saltern-Derived Bacillus sp. KCB14S006.

Authors:  Sangkeun Son; Sung-Kyun Ko; Mina Jang; Jong Won Kim; Gil Soo Kim; Jae Kyoung Lee; Eun Soo Jeon; Yushi Futamura; In-Ja Ryoo; Jung-Sook Lee; Hyuncheol Oh; Young-Soo Hong; Bo Yeon Kim; Shunji Takahashi; Hiroyuki Osada; Jae-Hyuk Jang; Jong Seog Ahn
Journal:  Mar Drugs       Date:  2016-04-02       Impact factor: 5.118

10.  Biosynthetic Potential of Bioactive Streptomycetes Isolated From Arid Region of the Thar Desert, Rajasthan (India).

Authors:  Meeta Masand; Kunjukrishnan Kamalakshi Sivakala; Ekta Menghani; Thangathurai Thinesh; Rangasamy Anandham; Gaurav Sharma; Natesan Sivakumar; Solomon R D Jebakumar; Polpass Arul Jose
Journal:  Front Microbiol       Date:  2018-04-18       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.